Results support possible benefits of Tysabri for MS patients

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Results support possible benefits of Tysabri for MS patients

Postby MSUK » Fri Oct 08, 2010 3:14 am

Image

Biogen Idec and Elan Corporation, plc have announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking Tysabri® (natalizumab) experienced an improvement in both their physical function and psychological well-being.

Findings from the study, which was performed in conjunction with HealthCore Inc., a health-outcomes research company, are the first attempt to assess patient experiences with Tysabri in usual-care settings. The data, presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), shows patients report Tysabri has an impact in improving their overall quality of life.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1768
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 1981
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Re: Results support possible benefits of Tysabri for MS pati

Postby HarryZ » Fri Oct 08, 2010 6:27 am

Healthcore is a large shareholder in Biogen/Idec and less than a year ago, publicly attacked James Mullen, Biogen's CEO, for selling massive amounts of stock for his personal gain...thus reducing the value of the company's shares.

Perhaps these testing results may be an attempt to bolster Tysabri's sales and improve the financial situation at Biogen. Just a thought.

Harry
User avatar
HarryZ
Family Elder
 
Posts: 2320
Joined: Tue May 25, 2004 3:00 pm
Location: London, ON, Canada


Return to Tysabri (Antegren or Natalizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users